Archives
-
In Vitro Drug Response Metrics in Cancer Research
2026-09-04
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of anticancer drug response. The framework has practical implications for assay design, endpoint selection, temporal sampling, and interpretation of combination studies.
-
Hydrocortisone in Controlled Delivery Research
2026-09-04
Hydrocortisone supports reproducible glucocorticoid receptor, barrier, inflammation, and neuroprotection studies while also serving as a practical benchmark for corticosteroid delivery systems. This guide connects bench formulation, cell-based assays, and PLGA microsphere design with workflow parameters and troubleshooting strategies.
-
Masitinib (AB1010) Workflow Guide
2026-09-03
Masitinib (AB1010) provides a DMSO-compatible approach for studying KIT, PDGFRα, and PDGFRβ inhibition in cancer, mast cell, and inflammatory disease models. It is appropriate for controlled kinase and cell-based workflows, but not for aqueous or ethanol-based assays, broad-spectrum kinase profiling, or direct clinical interpretation without system-specific validation.
-
AT-406 (SM-406): From IAP Binding to Cell Fate
2026-09-03
AT-406 (SM-406) offers a mechanistically rich tool for cancer research, linking IAP antagonism with apoptosis pathway activation in cancer cells. This article explains how recent structural insights into procaspase-8 complexes can improve experimental interpretation beyond routine apoptosis assay optimization.
-
Tin Mesoporphyrin IX: HO-1 Research Guide
2026-09-02
Tin Mesoporphyrin IX (chloride) gives researchers a nanomolar-affinity tool for separating heme oxygenase signaling from downstream redox and disease phenotypes. This workflow-focused guide shows how to apply it in heme oxygenase activity assay development, metabolic disease research, insulin resistance study design, and mechanistic HBV experiments.
-
KU-55933: ATM Kinase Inhibitor Workflow
2026-09-02
Build cleaner DNA damage response experiments with KU-55933 by separating ATM target engagement from downstream effects on Akt, proliferation, metabolism, and cell-cycle state. This workflow also shows how to use ATM perturbation as a discriminating control when investigating the nuclear cGAS–TRIM41–ORF2p axis described in a recent reference study.
-
Triacetin in Ocular and Cancer Assay Design
2026-09-01
Triacetin and glyceryl triacetate are more than formulation excipients: they can influence metabolic, ocular, and cancer research readouts. This evidence-based guide translates published nanoemulsion findings into practical assay controls, dose interpretation, and workflow decisions.
-
HyperPFU™ high-fidelity DNA polymerase Guide
2026-09-01
HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is suitable for blunt-ended products used in cloning and sequencing, but should not be selected for workflows that require 3′-A overhangs or sticky ends.
-
Amorolfine Hydrochloride in Yeast Integrity Assays
2026-08-31
Use Amorolfine Hydrochloride as a tunable chemical stressor to connect membrane-synthesis phenotypes with ploidy, cell size, and survival in budding yeast. This workflow combines controlled exposure, orthogonal integrity readouts, and ploidy-matched comparisons for fungal infection research and antifungal resistance studies.
-
IWR-1-endo: From Wnt Mechanism to Cell-State Assays
2026-08-31
IWR-1-endo is a Wnt signaling inhibitor that connects precise β-catenin pathway control with cell-state-aware assay design. This guide integrates its Axin-dependent mechanism with lessons from single-nucleus profiling in atrial fibrillation research.
-
SW033291: From PGE2 Signals to Repair Assays
2026-08-30
SW033291 is a potent 15-PGDH inhibitor for studying prostaglandin E2 elevation, regenerative signaling, and hematopoietic responses. This article presents an assay-centered framework that connects enzyme inhibition with functional muscle repair, stem cell behavior, and tissue regeneration research.
-
CLCC1 and Herpesvirus Nuclear Egress
2026-08-29
A bioRxiv study identifies the host protein CLCC1 as an essential factor for membrane fusion during herpes simplex virus 1 nuclear egress, a stage distinct from virally driven capsid budding. Genetic depletion caused perinuclear capsid accumulation, impaired viral release, and defects in nuclear pore complex insertion, linking herpesvirus egress to broader nuclear-envelope morphogenesis.
-
CUDC-907: Dual PI3K/HDAC Workflow Guide
2026-08-28
CUDC-907 (SKU A4097) provides a defined starting point for cell-based studies that require concurrent PI3K/AKT signaling pathway inhibition and histone deacetylase (HDAC) inhibition. It is intended for controlled scientific research workflows only, not for diagnostic, clinical, or therapeutic use.
-
Baicalin N1778: Reliable Cell Assays
2026-08-28
Baicalin (SKU N1778) offers a practical framework for improving reproducibility in viability, proliferation, and cytotoxicity workflows. This scenario-based guide addresses solubility, dose selection, assay interference, pathway interpretation, and product quality using product data and recent literature.
-
MK-1775: Separating Arrest from Cell Killing
2026-08-27
MK-1775, a selective Wee1 kinase inhibitor, is best evaluated through time-resolved assays that distinguish proliferation arrest from true cell killing. This guide combines Wee1 biology with a practical framework for interpreting checkpoint abrogation, drug sensitization, and assay artifacts.